Share on LinkedInShare on LinkedIn

ARTICLE · 04 OCTOBER 2019

AD-ttorneys@law – September 26, 2019

BakerHostetler
BakerHostetler
Contributor
BakerHostetler

BakerHostetler

Recognized as an innovator and one of the top firms for client service, BakerHostetler helps...

View firm profile
Explore more from BakerHostetler

Three unnamed companies were on the receiving end of firm but undoubtedly polite letters from the Federal Trade Commission warning them to take a long, hard look at their cannabidiol (CBD) advertising.

United StatesMedia, Telecoms, IT, Entertainment

Latest Round of FTC CBD Letter-Writing Campaign Has Anonymous Pen Pals

Three companies get talking-to over CBD health claims

Ambitious!

Three unnamed companies were on the receiving end of firm but undoubtedly polite letters from the Federal Trade Commission warning them to take a long, hard look at their cannabidiol (CBD) advertising.

Using scare quotes designed to make them seem like dangerously unhip parents, the commission announced that the missives were sent to "three companies that sell oils, tinctures, capsules, 'gummies,' and creams containing cannabidiol (CBD), a chemical compound derived from the cannabis plant."

Apparently the anonymous companies have been claiming that their CBD-related products cure or alleviate a variety of conditions, including (take a deep breath) cancer, Alzheimer's disease, arthritis, multiple sclerosis, cigarette addiction, colitis, autism, anorexia, bipolar disorder, post-traumatic stress disorder, schizophrenia,

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from